Has Meenakshi Davuluri, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,361 in general payments to Meenakshi Davuluri, MD across 35 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Meenakshi Davuluri, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Meenakshi Davuluri, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Meenakshi Davuluri, MD

Urology · Brooklyn, NYNPI 1043605330

Payments from drug & device makers

$3,361in general payments, 2019–2025

Across 35 payments — averaging $96.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$2K
Coloplast$1K
Procept Biorobotics Corporation$163
AstraZeneca$35
Telix Pharmaceuticals$19

What the payments were for

Travel & lodging$2,39071%
Food & beverage$93628%
Education$351%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	18	$1,843
Coloplast	12	$1,302
Procept Biorobotics Corporation	3	$163
AstraZeneca	1	$35
Telix Pharmaceuticals	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,361 in reported general payments places this provider in the 50th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024

$108,242

Medicare patients

281

Services billed

742

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MyrbetriqMirabegron	144	$95,623
GemtesaVibegron	23	$15,192
ElmironPentosan Polysulfate Sodium	17	$9,783
Solifenacin Succinate	102	$7,566
Mirabegron ErMirabegron	11	$6,489
Tamsulosin Hcl	177	$3,071
Trospium Chloride	46	$2,019
Trospium Chloride ErTrospium Chloride	11	$2,001
Potassium Citrate ErPotassium Citrate	27	$1,620
Estradiol	25	$1,609
Tadalafil	12	$1,577
Testosterone	13	$1,459
Alfuzosin Hcl ErAlfuzosin Hcl	51	$1,220
Finasteride	73	$901
Cefpodoxime Proxetil	23	$779

Paid to pharmacies, not to this prescriber.

Other urology in Brooklyn

William AtallahBrooklyn$191K
Ivan GrunbergerBrooklyn$159K
Christopher PieczonkaSyracuse$31.2M
Guarionex DecastroNew York$5.7M
Mitchell EfrosGarden City$4.2M
James McKiernanNew York$4.1M
William HuangNew York$3.9M
Jed KaminetskyMiddle Village$3.5M
Evan GoldfischerPoughkeepsie$3.1M
Gennady BratslavskySyracuse$2.5M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →